about
Cytogenetic abnormalities in three patients with B-cell prolymphocytic leukemia.[Persistent polyclonal B-cell lymphocytosis: study of 35 cases].Acute erythroid neoplastic proliferations. A biological study based on 62 patients.Detection of abnormalities of PRV-1, TPO, and c-MPL genes detected by fluorescence in situ hybridization in essential thrombocythemia.A new case of acute nonlymphocytic leukemia (French-American-British subtype M1) with double minutes and c-MYC amplification.Monosomy 15 in chronic myelomonocytic leukemia. description of a case and review of the literature.Genetic characterization of the paraimmunoblastic variant of small lymphocytic lymphoma/chronic lymphocytic leukemia: A case report and review of the literature.Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometryPARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors.Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.[Selective chromosome painting using in situ hybridization]Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.Blast cells with nuclear extrusions in the form of micronuclei are associated with MYC amplification in acute myeloid leukemia.Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3.[Abundant erythroblastic islands in bone marrow aspirate in a case of polycythemia vera. Various considerations on this anatomo-functional structure]TET2 gene is not deleted in chronic myelomonocytic leukemia: a FISH retrospective study.Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.Hairy cell leukemia with ringed-shaped nuclei.[Cytogenetic study of 93 myelodysplastic syndromes]Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia.[Omega-exonuclease: an enzymatic marker for basophilic leukocytes and mast cells]Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.[Study of granulocyte-monocyte stem cells (CFU-GM) in vitro from peripheral blood and bone marrow in various phases of chronic myeloid leukemia]Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients.Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size.Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation.Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia.Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significance.Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.Excessive lipid-phagocytosis of neutrophils in a patient with mesothelioma.Platelet peroxidase of circulating thrombocytes in acquired refractory anaemias.Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?
P50
Q32063231-3D589162-F2A4-4FC3-A183-F42C9962DB0DQ33844080-73A07CC5-7B0D-4127-9064-F606C45CEB05Q34522729-A291AACD-AE07-4CF6-ADD3-56455FD4D419Q34522929-8912EA3C-6733-4D5E-8676-6533B2102EBDQ34535081-D640183E-A3CF-4096-8AF9-63A34B64AC89Q34659531-57C3254F-9C87-4CA0-ADD6-8800E7C17575Q35010286-DD64EC04-9811-4199-B8AA-DA296AA18267Q35661305-DCC9926C-2378-46B5-B4FB-006664463E55Q35809271-445847A8-F0FA-4B98-AE32-644EF95EC2D6Q36056495-4BA7A040-E791-4B59-9C93-795AFC349A83Q36094707-BD202E6D-AA88-481C-9473-D40CCA9B08C8Q36785768-C40DC497-CD73-45C0-B9F6-1C13EDB090B5Q36862492-96AB88CF-156F-46F5-89EE-C0BDB69423A2Q38455157-6B53B400-C16A-40A6-BDD3-BEB90E5D510CQ38827726-FF43D054-B172-42D3-A6A0-155F71FBE936Q38844894-824A6F2D-80A9-49B8-8B67-EC31A880C33AQ38859549-B21B56B1-A473-43B9-88B4-4CF1A36572ECQ40160900-E4C9BCDE-92B2-4DDA-BEEE-B470FD466E8EQ41439053-C4426966-EE98-4623-884B-641885535445Q41652661-17D16208-916F-44A0-AE81-C7EC829DC1F3Q42415908-E9CEA740-FC3C-4F33-887A-6209E30FD739Q44114704-EF58E15D-CB7A-4660-9E0E-9280DF806921Q44306917-C6909813-D771-4CA5-8BF3-6680AFCB52C9Q44593487-0F97BAAE-3F32-4D64-A3CB-FD29ECAE9ECBQ44785343-335329F1-1483-4678-8692-548E4FD4589DQ44987934-2ED8E915-7FF1-4AD2-A623-D74E42CEB432Q45155324-EB164EE4-4147-4461-9DF1-C0B45F37E518Q45238175-6CBC661E-A103-44F3-BD2B-1124F49115A7Q45904545-CB587D95-6134-48DE-846E-C463156B6823Q45928632-75331595-9B21-4393-80B0-FEA856D1EB78Q47428574-E87035F6-7139-4BF8-807C-9BA3880FF880Q47723709-9A10C724-6C11-4D89-B230-6E3FFE093459Q51331405-38278BF2-C598-4474-B75A-788582CE144DQ52928211-E3E155BF-E5CA-4E45-BDF7-89C6E75D92C9Q53101662-FFF52D2F-4DBC-4CCC-B55C-F3DBC7D3B203Q53267488-7581F4D9-F4E2-48FF-8BDC-2CBC9EF49AF6Q53469016-CA27B0C9-B03D-4795-9B87-5FDEDCB0C192Q53519749-72775F13-0A2E-42D9-8EB9-EDBBA4A639B5Q53538421-A2887180-1C86-4903-A98C-BE5B98C0A0E7Q53835607-825CAB08-8C0D-4EEC-88C6-88DD77EBDA4A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lourdes Florensa
@ast
Lourdes Florensa
@en
Lourdes Florensa
@es
Lourdes Florensa
@nl
Lourdes Florensa
@sl
type
label
Lourdes Florensa
@ast
Lourdes Florensa
@en
Lourdes Florensa
@es
Lourdes Florensa
@nl
Lourdes Florensa
@sl
prefLabel
Lourdes Florensa
@ast
Lourdes Florensa
@en
Lourdes Florensa
@es
Lourdes Florensa
@nl
Lourdes Florensa
@sl
P106
P21
P31
P496
0000-0001-5906-3311